$Recro制药(REPH)$ 内部交易: 2022-01-18,CEO,ENLOE J DAVID JR ,买入,602普通股, $1.68
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-002423 Size: 4 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-002422 Size: 4 KB 网页链接
$Recro制药(REPH)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001193125-22-010539 Act: 33 Size: 234 KB 网页链接
$Recro制药(REPH)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0000950170-22-000333 Act: 34 Size: 402 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-000720 Size: 6 KB 网页链接
$Recro制药(REPH)$ 内部交易: 2021-12-21,10% Owner,AWM Investment Company, Inc. ,卖出,99398普通股, $1.55
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001535264-21-000054 Size: 5 KB 网页链接
$Recro制药(REPH)$ 内部交易: 2021-12-16,10% Owner,AWM Investment Company, Inc. ,卖出,50000普通股, $1.61
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001535264-21-000053 Size: 5 KB 网页链接